Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TWIST: Low Dose Ticagrelor in Stable CAD
NCT04206176Phase 2Completed
- Sponsor
- The University of the West Indies
- Start
- Oct 2019
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ticagrelor in coronary artery disease (CAD), sponsored by The University of the West Indies. Started Oct 2019; status: completed.
02
Drugs
ticagrelor
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT04206176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04206176.